COVID-19: a gray swan's impact on the adoption of novel medical technologies
Authors
Dunlap, DeniseSantos, Roberto S.
Lilly, Craig M.
Teebagy, Sean
Hafer, Nathaniel S.
Buchholz, Bryan O.
McManus, David D.
UMass Chan Affiliations
Center for Clinical and Translational ScienceMedicine
T.H. Chan School of Medicine
Document Type
Journal ArticlePublication Date
2022-07-08
Metadata
Show full item recordAbstract
The COVID-19 pandemic offers a unique context and opportunity to investigate changes in healthcare professional perceptions towards the adoption of novel medical technologies, such as point-of-care technologies (POCTs). POCTs are a nascent technology that has experienced rapid growth as a result of COVID-19 due to their ability to increase healthcare accessibility via near-patient delivery, including at-home. We surveyed healthcare professionals before and during COVID-19 to explore whether the pandemic altered their perceptions about the usefulness of POCTs. Our network analysis method provided a structure for understanding this changing phenomenon. We uncovered that POCTs are not only useful for diagnosing COVID-19, but healthcare professionals also perceive them as increasingly important for diagnosing other diseases, such as cardiovascular, endocrine, respiratory, and metabolic diseases. Healthcare professionals also viewed POCTs as facilitating the humanization of epidemiology by improving disease management/monitoring and strengthening the clinician-patient relationship. As the accuracy and integration of these technologies into mainstream healthcare delivery improves, hurdles to their adoption dissipate, thereby encouraging healthcare professionals to rely upon them more frequently to diagnose, manage, and monitor diseases. The technological advances made in POCTs during COVID-19, combined with shifting positive perceptions of their utility by healthcare professionals, may better prepare us for the next pandemic.Source
Dunlap DR, Santos RS, Lilly CM, Teebagy S, Hafer NS, Buchholz BO, McManus DD. COVID-19: a gray swan's impact on the adoption of novel medical technologies. Humanit Soc Sci Commun. 2022;9(1):232. doi: 10.1057/s41599-022-01247-9. Epub 2022 Jul 8. PMID: 35821762; PMCID: PMC9263801.DOI
10.1057/s41599-022-01247-9Permanent Link to this Item
http://hdl.handle.net/20.500.14038/51134PubMed ID
35821762Related Resources
The study data files are publicly deposited in UMass Chan Medical School’s institutional repository, eScholarship@UMassChan. The permanent link to the data is https://doi.org/10.13028/dtb5-q194.Rights
© The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.ae974a485f413a2113503eed53cd6c53
10.1057/s41599-022-01247-9